Individuals with many different psychiatric disorders have a higher tendency to choose smaller, immediate rewards over larger, delayed rewards, a study led by Hamilton researchers has found.

The findings of a meta-analysis by researchers of McMaster University and St. Joseph’s Healthcare Hamilton, which combined data from more than 40 studies, was published in JAMA Psychiatry today.

That this type of decision-making tied to impulsivity, called delay discounting, is heightened in those with certain psychiatric disorders compared to others, is expected to have an important impact on future research and treatment across an array of disorders.

“The revelation that delay discounting is one of these ‘trans-diagnostic’ processes will have a significant effect on the future of psychiatric diagnosis and treatment,” said Michael Amlung, lead author of the study. He is an assistant professor of psychiatry and behavioural neurosciences at McMaster University and researcher for the Peter Boris Centre for Addictions Research at St. Joseph’s Healthcare Hamilton.

The study analyzed data from studies across eight different psychiatric disorders, including major depressive disorder, bipolar disorder, borderline personality disorder, schizophrenia, eating disorders, and others. The largest delay discounting effects were found to be associated with bipolar disorder, borderline personality disorder, and schizophrenia.

Previous research has linked a greater preference for immediate rewards and impulsivity to negative health outcomes, such as addiction, obesity, and ADHD. This study reinforced that negative association, finding that impulsive preferences are consistently observed across an even broader range of psychiatric disorders.

Interestingly, the study also found the opposite pattern in those with anorexia nervosa. The researchers explained that the greater preference for delayed over immediate rewards seen in people with anorexia is consistent with excessive self-control of their eating habits.

The study authors say this pattern suggests that delay discounting preferences are best thought of as being on a continuum, with some disorders exhibiting excessively impulsive decisions and other disorders exhibiting excessively self-controlled decisions.

“Examining factors that cut across psychiatric disorders, such as delay discounting, helps to illuminate commonalities and distinguishing characteristics amongst disorders that then guide further research on treatment and prevention,” said Randi McCabe, co-author of the paper, psychologist-in-chief at St. Joseph’s Healthcare Hamilton and professor of psychiatry and behavioural neurosciences at McMaster.

“The more we understand the nature of psychiatric illness, the better we are equipped to provide effective treatment strategies,” she said.

The authors say the study findings support the inclusion of delay discounting in the Research Domain Criteria (RDoC) framework proposed by the National Institute of Mental Health, as a potent indicator of psychiatric illness. RDoC is a biologically-valid framework for understanding mental disorders, and includes research approaches in genetics, neuroscience, and behavioural science.

“Our results provide strong evidence for delay discounting as a core behavioural process within the RDoC framework,” Amlung said. “On a broader level, this study underscores the need for future research examining common neurobiological and genetic underpinnings of this type of decision making in order to inform evidence-based treatments across psychiatric disorders.”

The Peter Boris Centre for Addictions Research, a partnership of St. Joseph’s Healthcare Hamilton and McMaster University, partially funded this study.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What has leaves, a trunk, and branches, and grows in forests?

Explore More

Groundbreaking antidiabetic compound unveiled: HPH-15 reduces blood glucose level and combats fat accumulation

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment innovation. Type

Disordered eating is not only a disease of affluent girls

Predominant stereotypes about eating disorders suggest that it is a condition mainly associated with girls from wealthy backgrounds. However, a new study from Michigan State University found that boys living

Deadly diets driving digestive diseases

Against the backdrop of an alarming increase in the number of people under 50 being diagnosed with bowel cancer, researchers are urging people to bump up their fibre intake and